A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study

A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study

Item

http://www.wikidata.org/entity/Q30431721

Q30431721

about

In 2014, can we do better than CA125 in the early detection of ovarian cancer?Ovarian cancer screening--current status, future directions Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer Challenging and complex decisions in the management of the BRCA mutation carrier Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.Development and preliminary evaluation of a multivariate index assay for ovarian cancer.Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.Nursing research in the Gynecologic Oncology Group.Translational research in the Gynecologic Oncology Group: evaluation of ovarian cancer markers, profiles, and novel therapies.An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers.Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States.New views on the pathogenesis of high-grade pelvic serous carcinoma with suggestions for advancing future research Ovarian cancer screening: development of the risk of ovarian cancer algorithm (ROCA) and ROCA screening trials.Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer.Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status.The fallopian tube: from back stage to center stage.A screening and prevention programme serving an ethnically diverse population of women at high risk of developing breast and/or ovarian cancer.A terrible beauty: a physician's story of ovarian cancer.Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers.Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancer Health-related quality of life in ovarian cancer patients and its impact on clinical management Cancer genetic association studies in the genome-wide age.Genetic risk and gynecologic cancers.Recent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer.Ovarian cancer screening and early detection.Hereditary gynaecological malignancies: advances in screening and treatment.Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspective Options in Prophylactic Surgery to Prevent Ovarian Cancer in High-Risk Women: How New Hypotheses of Fallopian Tube Origin Influence Recommendations.Bone loss after oophorectomy among high-risk women: an NRG oncology/gynecologic oncology group study.Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.What have we learned from risk-reducing salpingo-oophorectomy?"Best practices in risk reducing bilateral salpingo-oophorectomy: the influence of surgical specialty".Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening†

P2860

Q26825152-7D720E6E-6E69-4E34-AA4C-87436B6DC2D8 Q27004471-BFF96B78-7EC1-456A-B3DA-2AEF59FE4BEC Q27009306-168994AF-2A0F-49B1-AFD3-F9544D31AB9D Q27026559-C98614BA-DF8C-491C-BBCB-C476A8680081 Q28741004-5157E45C-D40C-4364-8B49-B7D33DFE1C5E Q30370475-614DF2E5-32E6-49E6-BC16-53483491C63F Q30858808-CCE9017C-9F62-4235-ABD5-918FD0F893B0 Q31001228-EE32C55C-425D-4442-B24E-CABED2220193 Q33551371-5146B65F-367F-4F10-A803-5271CF640418 Q33880468-BBDE4D06-5633-4B22-B8D6-BDAF0516DC04 Q33901361-B02DCD12-DFD4-4FE7-BFE2-F5741DA558B8 Q34125241-7C0A45AC-990D-42D1-B16C-FDA76BC750ED Q34152848-6AE82A7B-79E3-44AA-96D0-D30663F3A7F8 Q34309892-06C131B0-7DFB-4C01-B597-7591DEF57132 Q34343315-D4F9CD1D-E398-422E-A574-34977DF4113B Q34543315-67C71B60-6E34-4066-A2FB-2A822C336AD5 Q34637879-1434F643-EF04-47E1-9B33-9D0C6594C2FA Q35076152-9C925C10-F5F5-4B76-826B-AB604D4DCD40 Q35212074-E2DC0553-B28F-4F58-8809-67806F117F66 Q35562911-84736179-6B9B-4425-8706-963FC915D85E Q35572946-E4DEB62E-44BF-4060-BDF5-93FA3970C7C6 Q35941981-E560AD97-BA10-478C-B5DD-F8C00D3DBAF6 Q36313479-87EFAB34-8F69-49DD-A354-11911D185044 Q36634141-C3FC2EAA-C66A-4D37-B804-0590DF302346 Q36894026-768474DE-DB1B-43EB-83ED-78BB780F5109 Q37036780-6A8B610E-BDB7-4B3F-9464-1DC199C2B389 Q37137088-C839DA8A-3A20-4DFB-8CB8-6FDACF940AAC Q37468316-1FFC6E6B-3B91-41BB-A6AD-0FB2F6D0759F Q37620476-FE8EABF1-C62D-4C49-AED5-8713425CD92B Q37622987-17C75765-0637-4C96-852A-7C43A13FBE69 Q38067433-4559AA8D-7A8E-4FEB-B53C-E91C2AE01355 Q38599703-E533D62D-528C-4F5E-83C9-1C80E9D34082 Q38649539-0FE004AC-CE20-43B9-9CD6-663CA51BB52F Q38794773-11750FB7-0E61-46AD-BA5B-58A9C56550B8 Q38806489-0592E75A-5D77-4A05-9488-871EA5F60B2F Q38964976-E53EFE76-C14A-4515-B150-D4DB1D9193C6 Q38988184-81692261-591F-4788-BA54-AD4AE67B8C69 Q43184175-0F659BA9-5430-441F-89CF-A962DC6D019B Q47162185-6143A4F7-35E4-43A8-B29C-8673369D549A Q59273721-A99A63BE-645A-4932-8997-D2B04D68A24D

P2860

A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: design and baseline characteristics: a Gynecologic Oncology Group study

Item

http://www.wikidata.org/entity/Q30431721

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu